Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 15-Oct-24 1:45 PM View:  | Townsend Richard Nolan Chief Executive Officer Director | Lexeo Therapeutics, Inc. (LXEO) | 10-Oct-24 | Planned Option Sale | 5,000 | $8.10 | $40,495.50 | (4%) 125.69K to 120.69K | |
| 15-Oct-24 1:45 PM View: | Townsend Richard Nolan Chief Executive Officer Director | Lexeo Therapeutics, Inc. (LXEO) | 10-Oct-24 | Option Exercise | 5,000 | $2.33 | $11,650.00 | 4% 120.69K to 125.69K | |
| 11-Sep-24 5:17 PM View: | Townsend Richard Nolan Chief Executive Officer Director | Lexeo Therapeutics, Inc. (LXEO) | 10-Sep-24 | Planned Option Sale | 5,000 | $10.65 | $53,273.50 | (4%) 125.69K to 120.69K | |
| 11-Sep-24 5:17 PM View: | Townsend Richard Nolan Chief Executive Officer Director | Lexeo Therapeutics, Inc. (LXEO) | 10-Sep-24 | Option Exercise | 5,000 | $2.33 | $11,650.00 | 4% 120.69K to 125.69K | |
| 13-Aug-24 6:34 PM View: | Townsend Richard Nolan Chief Executive Officer Director | Lexeo Therapeutics, Inc. (LXEO) | 12-Aug-24 | Option Exercise | 5,000 | $2.33 | $11,650.00 | 4% 120.69K to 125.69K | |
| 13-Aug-24 6:34 PM View: | Townsend Richard Nolan Chief Executive Officer Director | Lexeo Therapeutics, Inc. (LXEO) | 12-Aug-24 | Planned Option Sale | 5,000 | $11.53 | $57,634.50 | (4%) 125.69K to 120.69K | |
| 12-Jul-24 4:55 PM View: | Townsend Richard Nolan Chief Executive Officer Director | Lexeo Therapeutics, Inc. (LXEO) | 11-Jul-24 | Sale (Planned) | 28,031 | $17.07 | $478,409.00 | (19%) 148.73K to 120.69K | |
| 12-Jul-24 4:55 PM View: | Townsend Richard Nolan Chief Executive Officer Director | Lexeo Therapeutics, Inc. (LXEO) | 10-Jul-24 | Sale (Planned) | 21,969 | $16.50 | $362,481.00 | (13%) 170.69K to 148.73K | |
| 12-Jul-24 4:55 PM View: | Townsend Richard Nolan Chief Executive Officer Director | Lexeo Therapeutics, Inc. (LXEO) | 10-Jul-24 | Option Exercise | 5,000 | $2.33 | $11,650.00 | 3% 170.69K to 175.69K | |
| 12-Jul-24 4:55 PM View: | Townsend Richard Nolan Chief Executive Officer Director | Lexeo Therapeutics, Inc. (LXEO) | 10-Jul-24 | Planned Option Sale | 5,000 | $16.50 | $82,498.20 | (3%) 175.69K to 170.69K | |
| 14-Jun-24 9:04 AM View: | Otero Jose Manuel Chief Technical Officer | Lexeo Therapeutics, Inc. (LXEO) | 12-Jun-24 | Grant | 31,250 | -- | -- | 100% 0 to 31.25K | |
| 12-Jun-24 5:00 PM View: | Townsend Richard Nolan Chief Executive Officer Director | Lexeo Therapeutics, Inc. (LXEO) | 10-Jun-24 | Option Exercise | 5,000 | $2.33 | $11,650.00 | 3% 170.69K to 175.69K | |
| 12-Jun-24 5:00 PM View: | Townsend Richard Nolan Chief Executive Officer Director | Lexeo Therapeutics, Inc. (LXEO) | 10-Jun-24 | Planned Option Sale | 5,000 | $17.65 | $88,263.80 | (3%) 175.69K to 170.69K | |
| 14-May-24 4:04 PM View: | Townsend Richard Nolan Chief Executive Officer Director | Lexeo Therapeutics, Inc. (LXEO) | 13-May-24 | Planned Option Sale | 5,000 | $13.22 | $66,093.00 | (3%) 175.69K to 170.69K | |
| 14-May-24 4:04 PM View: | Townsend Richard Nolan Chief Executive Officer Director | Lexeo Therapeutics, Inc. (LXEO) | 13-May-24 | Option Exercise | 5,000 | $2.33 | $11,650.00 | 3% 170.69K to 175.69K | |
| 06-Feb-24 5:56 PM View: | Adler Eric Chief Medical Officer | Lexeo Therapeutics, Inc. (LXEO) | 02-Feb-24 | Grant | 26,875 | -- | -- | 100% 0 to 26.88K | |
| 09-Jan-24 6:52 PM View: | Townsend Richard Nolan Chief Executive Officer Director | Lexeo Therapeutics, Inc. (LXEO) | 05-Jan-24 | Grant | 43,750 | -- | -- | 34% 126.94K to 170.69K | |
| 09-Jan-24 6:50 PM View: | Robertson Jenny Chief Legal and Admin Officer | Lexeo Therapeutics, Inc. (LXEO) | 05-Jan-24 | Grant | 23,750 | -- | -- | 100% 0 to 23.75K | |
| 09-Nov-23 8:32 PM View: | Longitude Capital Partners ... 10% Owner | Lexeo Therapeutics, Inc. (LXEO) | 07-Nov-23 | Conversion | 2,112,560 | -- | -- | 100% 0 to 2.11M | |
| 09-Nov-23 8:33 PM View: | Lundbeckfond Invest A/s 10% Owner | Lexeo Therapeutics, Inc. (LXEO) | 07-Nov-23 | Purchase | 227,272 | $11.00 | $2,499,990.00 | 14% 1.61M to 1.84M | |
| 09-Nov-23 8:36 PM View: | Omega Fund Vi, L.P. 10% Owner | Lexeo Therapeutics, Inc. (LXEO) | 07-Nov-23 | Purchase | 454,545 | $11.00 | $5,000,000.00 | 27% 1.7M to 2.16M | |
| 09-Nov-23 8:32 PM View: | Longitude Capital Partners ... 10% Owner | Lexeo Therapeutics, Inc. (LXEO) | 07-Nov-23 | Purchase Duplicate | 454,545 | $11.00 | $5,000,000.00 | 22% 2.11M to 2.57M | |
| 09-Nov-23 8:35 PM View: | McCormac Paul Chief Technical Officer | Lexeo Therapeutics, Inc. (LXEO) | 07-Nov-23 | Conversion | 3,191 | -- | -- | 23% 14.16K to 17.35K | |
| 09-Nov-23 8:33 PM View: | Lundbeckfond Invest A/s 10% Owner | Lexeo Therapeutics, Inc. (LXEO) | 07-Nov-23 | Conversion | 1,608,690 | -- | -- | 100% 0 to 1.61M | |
| 09-Nov-23 8:36 PM View: | Omega Fund Vi, L.P. 10% Owner | Lexeo Therapeutics, Inc. (LXEO) | 07-Nov-23 | Conversion | 1,703,080 | -- | -- | 100% 0 to 1.7M |
